The ADMIN-ICU survey: a survey on antimicrobial dosing and monitoring in ICUs.
Identifieur interne : 002611 ( PubMed/Checkpoint ); précédent : 002610; suivant : 002612The ADMIN-ICU survey: a survey on antimicrobial dosing and monitoring in ICUs.
Auteurs : Alexis Tabah [Oman] ; Jan De Waele [Belgique] ; Jeffrey Lipman [Australie] ; Jean Ralph Zahar [France] ; Menino Osbert Cotta [Australie] ; Greg Barton [Royaume-Uni] ; Jean-Francois Timsit [France] ; Jason A. Roberts [Australie]Source :
- The Journal of antimicrobial chemotherapy [ 1460-2091 ] ; 2015.
Descripteurs français
- KwdFr :
- MESH :
- administration et posologie : Antibactériens.
- Enquêtes et questionnaires, Humains, Surveillance pharmacologique, Unités de soins intensifs.
English descriptors
- KwdEn :
- MESH :
- chemical , administration & dosage : Anti-Bacterial Agents.
- methods : Drug Monitoring.
- Humans, Intensive Care Units, Surveys and Questionnaires.
Abstract
There is little evidence and few guidelines to inform the most appropriate dosing and monitoring for antimicrobials in the ICU. We aimed to survey current practices around the world.
DOI: 10.1093/jac/dkv165
PubMed: 26169558
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:26169558Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The ADMIN-ICU survey: a survey on antimicrobial dosing and monitoring in ICUs.</title><author><name sortKey="Tabah, Alexis" sort="Tabah, Alexis" uniqKey="Tabah A" first="Alexis" last="Tabah">Alexis Tabah</name><affiliation wicri:level="1"><nlm:affiliation>Intensive Care Unit, The Royal Brisbane and Women's Hospital, Brisbane, Australia Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane, Australia alextabah@gmail.com.</nlm:affiliation><country wicri:rule="url">Oman</country><wicri:regionArea>Intensive Care Unit, The Royal Brisbane and Women's Hospital, Brisbane, Australia Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane</wicri:regionArea><wicri:noRegion>Brisbane</wicri:noRegion></affiliation></author><author><name sortKey="De Waele, Jan" sort="De Waele, Jan" uniqKey="De Waele J" first="Jan" last="De Waele">Jan De Waele</name><affiliation wicri:level="1"><nlm:affiliation>Department of Critical Care Medicine, Ghent University Hospital, Ghent, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Department of Critical Care Medicine, Ghent University Hospital, Ghent</wicri:regionArea><wicri:noRegion>Ghent</wicri:noRegion></affiliation></author><author><name sortKey="Lipman, Jeffrey" sort="Lipman, Jeffrey" uniqKey="Lipman J" first="Jeffrey" last="Lipman">Jeffrey Lipman</name><affiliation wicri:level="1"><nlm:affiliation>Intensive Care Unit, The Royal Brisbane and Women's Hospital, Brisbane, Australia Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane, Australia Faculty of Health, Queensland University of Technology, Brisbane, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Intensive Care Unit, The Royal Brisbane and Women's Hospital, Brisbane, Australia Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane, Australia Faculty of Health, Queensland University of Technology, Brisbane</wicri:regionArea><wicri:noRegion>Brisbane</wicri:noRegion></affiliation></author><author><name sortKey="Zahar, Jean Ralph" sort="Zahar, Jean Ralph" uniqKey="Zahar J" first="Jean Ralph" last="Zahar">Jean Ralph Zahar</name><affiliation wicri:level="3"><nlm:affiliation>Unité de Prévention et de Lutte contre les Infections Nosocomiales, CHU Angers - Université D'Angers, Angers, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Unité de Prévention et de Lutte contre les Infections Nosocomiales, CHU Angers - Université D'Angers, Angers</wicri:regionArea><placeName><region type="region">Pays de la Loire</region><region type="old region">Pays de la Loire</region><settlement type="city">Angers</settlement></placeName></affiliation></author><author><name sortKey="Cotta, Menino Osbert" sort="Cotta, Menino Osbert" uniqKey="Cotta M" first="Menino Osbert" last="Cotta">Menino Osbert Cotta</name><affiliation wicri:level="1"><nlm:affiliation>Intensive Care Unit, The Royal Brisbane and Women's Hospital, Brisbane, Australia Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Intensive Care Unit, The Royal Brisbane and Women's Hospital, Brisbane, Australia Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane</wicri:regionArea><wicri:noRegion>Brisbane</wicri:noRegion></affiliation></author><author><name sortKey="Barton, Greg" sort="Barton, Greg" uniqKey="Barton G" first="Greg" last="Barton">Greg Barton</name><affiliation wicri:level="1"><nlm:affiliation>Pharmacy Department, St Helens and Knowsley Teaching Hospitals NHS Trust, Liverpool, UK School of Pharmacy & Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Pharmacy Department, St Helens and Knowsley Teaching Hospitals NHS Trust, Liverpool, UK School of Pharmacy & Biomolecular Sciences, Liverpool John Moores University, Liverpool</wicri:regionArea><wicri:noRegion>Liverpool</wicri:noRegion></affiliation></author><author><name sortKey="Timsit, Jean Francois" sort="Timsit, Jean Francois" uniqKey="Timsit J" first="Jean-Francois" last="Timsit">Jean-Francois Timsit</name><affiliation wicri:level="1"><nlm:affiliation>APHP - Hopital Bichat - Reanimation Medicale et des maladies infectieuses, F-75018 Paris, France UMR 1137 - IAME Team 5 - DeSCID: Decision SCiences in Infectious Diseases, control and care; Inserm/Univ Paris Diderot, Sorbonne Paris Cité, F-75018 Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>APHP - Hopital Bichat - Reanimation Medicale et des maladies infectieuses, F-75018 Paris, France UMR 1137 - IAME Team 5 - DeSCID: Decision SCiences in Infectious Diseases, control and care; Inserm/Univ Paris Diderot, Sorbonne Paris Cité, F-75018 Paris</wicri:regionArea><wicri:noRegion>75018 Paris</wicri:noRegion><wicri:noRegion>75018 Paris</wicri:noRegion></affiliation></author><author><name sortKey="Roberts, Jason A" sort="Roberts, Jason A" uniqKey="Roberts J" first="Jason A" last="Roberts">Jason A. Roberts</name><affiliation wicri:level="1"><nlm:affiliation>Intensive Care Unit, The Royal Brisbane and Women's Hospital, Brisbane, Australia Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Intensive Care Unit, The Royal Brisbane and Women's Hospital, Brisbane, Australia Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane</wicri:regionArea><wicri:noRegion>Brisbane</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:26169558</idno><idno type="pmid">26169558</idno><idno type="doi">10.1093/jac/dkv165</idno><idno type="wicri:Area/PubMed/Corpus">002A14</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002A14</idno><idno type="wicri:Area/PubMed/Curation">002944</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002944</idno><idno type="wicri:Area/PubMed/Checkpoint">002944</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002944</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The ADMIN-ICU survey: a survey on antimicrobial dosing and monitoring in ICUs.</title><author><name sortKey="Tabah, Alexis" sort="Tabah, Alexis" uniqKey="Tabah A" first="Alexis" last="Tabah">Alexis Tabah</name><affiliation wicri:level="1"><nlm:affiliation>Intensive Care Unit, The Royal Brisbane and Women's Hospital, Brisbane, Australia Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane, Australia alextabah@gmail.com.</nlm:affiliation><country wicri:rule="url">Oman</country><wicri:regionArea>Intensive Care Unit, The Royal Brisbane and Women's Hospital, Brisbane, Australia Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane</wicri:regionArea><wicri:noRegion>Brisbane</wicri:noRegion></affiliation></author><author><name sortKey="De Waele, Jan" sort="De Waele, Jan" uniqKey="De Waele J" first="Jan" last="De Waele">Jan De Waele</name><affiliation wicri:level="1"><nlm:affiliation>Department of Critical Care Medicine, Ghent University Hospital, Ghent, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Department of Critical Care Medicine, Ghent University Hospital, Ghent</wicri:regionArea><wicri:noRegion>Ghent</wicri:noRegion></affiliation></author><author><name sortKey="Lipman, Jeffrey" sort="Lipman, Jeffrey" uniqKey="Lipman J" first="Jeffrey" last="Lipman">Jeffrey Lipman</name><affiliation wicri:level="1"><nlm:affiliation>Intensive Care Unit, The Royal Brisbane and Women's Hospital, Brisbane, Australia Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane, Australia Faculty of Health, Queensland University of Technology, Brisbane, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Intensive Care Unit, The Royal Brisbane and Women's Hospital, Brisbane, Australia Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane, Australia Faculty of Health, Queensland University of Technology, Brisbane</wicri:regionArea><wicri:noRegion>Brisbane</wicri:noRegion></affiliation></author><author><name sortKey="Zahar, Jean Ralph" sort="Zahar, Jean Ralph" uniqKey="Zahar J" first="Jean Ralph" last="Zahar">Jean Ralph Zahar</name><affiliation wicri:level="3"><nlm:affiliation>Unité de Prévention et de Lutte contre les Infections Nosocomiales, CHU Angers - Université D'Angers, Angers, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Unité de Prévention et de Lutte contre les Infections Nosocomiales, CHU Angers - Université D'Angers, Angers</wicri:regionArea><placeName><region type="region">Pays de la Loire</region><region type="old region">Pays de la Loire</region><settlement type="city">Angers</settlement></placeName></affiliation></author><author><name sortKey="Cotta, Menino Osbert" sort="Cotta, Menino Osbert" uniqKey="Cotta M" first="Menino Osbert" last="Cotta">Menino Osbert Cotta</name><affiliation wicri:level="1"><nlm:affiliation>Intensive Care Unit, The Royal Brisbane and Women's Hospital, Brisbane, Australia Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Intensive Care Unit, The Royal Brisbane and Women's Hospital, Brisbane, Australia Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane</wicri:regionArea><wicri:noRegion>Brisbane</wicri:noRegion></affiliation></author><author><name sortKey="Barton, Greg" sort="Barton, Greg" uniqKey="Barton G" first="Greg" last="Barton">Greg Barton</name><affiliation wicri:level="1"><nlm:affiliation>Pharmacy Department, St Helens and Knowsley Teaching Hospitals NHS Trust, Liverpool, UK School of Pharmacy & Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Pharmacy Department, St Helens and Knowsley Teaching Hospitals NHS Trust, Liverpool, UK School of Pharmacy & Biomolecular Sciences, Liverpool John Moores University, Liverpool</wicri:regionArea><wicri:noRegion>Liverpool</wicri:noRegion></affiliation></author><author><name sortKey="Timsit, Jean Francois" sort="Timsit, Jean Francois" uniqKey="Timsit J" first="Jean-Francois" last="Timsit">Jean-Francois Timsit</name><affiliation wicri:level="1"><nlm:affiliation>APHP - Hopital Bichat - Reanimation Medicale et des maladies infectieuses, F-75018 Paris, France UMR 1137 - IAME Team 5 - DeSCID: Decision SCiences in Infectious Diseases, control and care; Inserm/Univ Paris Diderot, Sorbonne Paris Cité, F-75018 Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>APHP - Hopital Bichat - Reanimation Medicale et des maladies infectieuses, F-75018 Paris, France UMR 1137 - IAME Team 5 - DeSCID: Decision SCiences in Infectious Diseases, control and care; Inserm/Univ Paris Diderot, Sorbonne Paris Cité, F-75018 Paris</wicri:regionArea><wicri:noRegion>75018 Paris</wicri:noRegion><wicri:noRegion>75018 Paris</wicri:noRegion></affiliation></author><author><name sortKey="Roberts, Jason A" sort="Roberts, Jason A" uniqKey="Roberts J" first="Jason A" last="Roberts">Jason A. Roberts</name><affiliation wicri:level="1"><nlm:affiliation>Intensive Care Unit, The Royal Brisbane and Women's Hospital, Brisbane, Australia Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Intensive Care Unit, The Royal Brisbane and Women's Hospital, Brisbane, Australia Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane</wicri:regionArea><wicri:noRegion>Brisbane</wicri:noRegion></affiliation></author></analytic><series><title level="j">The Journal of antimicrobial chemotherapy</title><idno type="eISSN">1460-2091</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anti-Bacterial Agents (administration & dosage)</term><term>Drug Monitoring (methods)</term><term>Humans</term><term>Intensive Care Units</term><term>Surveys and Questionnaires</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Antibactériens (administration et posologie)</term><term>Enquêtes et questionnaires</term><term>Humains</term><term>Surveillance pharmacologique ()</term><term>Unités de soins intensifs</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Anti-Bacterial Agents</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Antibactériens</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Drug Monitoring</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Intensive Care Units</term><term>Surveys and Questionnaires</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Enquêtes et questionnaires</term><term>Humains</term><term>Surveillance pharmacologique</term><term>Unités de soins intensifs</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">There is little evidence and few guidelines to inform the most appropriate dosing and monitoring for antimicrobials in the ICU. We aimed to survey current practices around the world.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26169558</PMID><DateCreated><Year>2015</Year><Month>08</Month><Day>18</Day></DateCreated><DateCompleted><Year>2016</Year><Month>05</Month><Day>09</Day></DateCompleted><DateRevised><Year>2015</Year><Month>08</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-2091</ISSN><JournalIssue CitedMedium="Internet"><Volume>70</Volume><Issue>9</Issue><PubDate><Year>2015</Year><Month>Sep</Month></PubDate></JournalIssue><Title>The Journal of antimicrobial chemotherapy</Title><ISOAbbreviation>J. Antimicrob. Chemother.</ISOAbbreviation></Journal><ArticleTitle>The ADMIN-ICU survey: a survey on antimicrobial dosing and monitoring in ICUs.</ArticleTitle><Pagination><MedlinePgn>2671-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jac/dkv165</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">There is little evidence and few guidelines to inform the most appropriate dosing and monitoring for antimicrobials in the ICU. We aimed to survey current practices around the world.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">An online structured questionnaire was developed and sent by e-mail to obtain information on local antimicrobial prescribing practices for glycopeptides, piperacillin/tazobactam, carbapenems, aminoglycosides and colistin.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 402 professionals from 328 hospitals in 53 countries responded, of whom 78% were specialists in intensive care medicine (41% intensive care, 30% anaesthesiology, 14% internal medicine) and 12% were pharmacists. Vancomycin was used as a continuous infusion in 31% of units at a median (IQR) daily dose of 25 (25-30) mg/kg. Piperacillin/tazobactam was used as an extended infusion by 22% and as a continuous infusion by 7%. An extended infusion of carbapenem (meropenem or imipenem) was used by 27% and a continuous infusion by 5%. Colistin was used at a daily dose of 7.5 (3.9-9) million IU (MIU)/day, predominantly as a short infusion. The most commonly used aminoglycosides were gentamicin (55%) followed by amikacin (40%), with administration as a single daily dose reported in 94% of the cases. Gentamicin was used at a daily dose of 5 (5-6) mg/day and amikacin at a daily dose of 15 (15-20) mg/day. Therapeutic drug monitoring of vancomycin, piperacillin/tazobactam and meropenem was used by 74%, 1% and 2% of the respondents, respectively. Peak aminoglycoside concentrations were sampled daily by 28% and trough concentrations in all patients by 61% of the respondents.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We found wide variability in reported practices for antibiotic dosing and monitoring. Research is required to develop evidence-based guidelines to standardize practices.</AbstractText><CopyrightInformation>© The Author 2015. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tabah</LastName><ForeName>Alexis</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, The Royal Brisbane and Women's Hospital, Brisbane, Australia Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane, Australia alextabah@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Waele</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Ghent University Hospital, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lipman</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, The Royal Brisbane and Women's Hospital, Brisbane, Australia Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane, Australia Faculty of Health, Queensland University of Technology, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zahar</LastName><ForeName>Jean Ralph</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Unité de Prévention et de Lutte contre les Infections Nosocomiales, CHU Angers - Université D'Angers, Angers, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cotta</LastName><ForeName>Menino Osbert</ForeName><Initials>MO</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, The Royal Brisbane and Women's Hospital, Brisbane, Australia Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barton</LastName><ForeName>Greg</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Pharmacy Department, St Helens and Knowsley Teaching Hospitals NHS Trust, Liverpool, UK School of Pharmacy & Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Timsit</LastName><ForeName>Jean-Francois</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>APHP - Hopital Bichat - Reanimation Medicale et des maladies infectieuses, F-75018 Paris, France UMR 1137 - IAME Team 5 - DeSCID: Decision SCiences in Infectious Diseases, control and care; Inserm/Univ Paris Diderot, Sorbonne Paris Cité, F-75018 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>Jason A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, The Royal Brisbane and Women's Hospital, Brisbane, Australia Burns, Trauma, and Critical Care Research Centre, The University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Working Group for Antimicrobial Use in the ICU within the Infection Section of the European Society of Intensive Care Medicine (ESICM)</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>07</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Antimicrob Chemother</MedlineTA><NlmUniqueID>7513617</NlmUniqueID><ISSNLinking>0305-7453</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016903" MajorTopicYN="N">Drug Monitoring</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>03</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>05</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26169558</ArticleId><ArticleId IdType="pii">dkv165</ArticleId><ArticleId IdType="doi">10.1093/jac/dkv165</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Australie</li><li>Belgique</li><li>France</li><li>Oman</li><li>Royaume-Uni</li></country><region><li>Pays de la Loire</li></region><settlement><li>Angers</li></settlement></list><tree><country name="Oman"><noRegion><name sortKey="Tabah, Alexis" sort="Tabah, Alexis" uniqKey="Tabah A" first="Alexis" last="Tabah">Alexis Tabah</name></noRegion></country><country name="Belgique"><noRegion><name sortKey="De Waele, Jan" sort="De Waele, Jan" uniqKey="De Waele J" first="Jan" last="De Waele">Jan De Waele</name></noRegion></country><country name="Australie"><noRegion><name sortKey="Lipman, Jeffrey" sort="Lipman, Jeffrey" uniqKey="Lipman J" first="Jeffrey" last="Lipman">Jeffrey Lipman</name></noRegion><name sortKey="Cotta, Menino Osbert" sort="Cotta, Menino Osbert" uniqKey="Cotta M" first="Menino Osbert" last="Cotta">Menino Osbert Cotta</name><name sortKey="Roberts, Jason A" sort="Roberts, Jason A" uniqKey="Roberts J" first="Jason A" last="Roberts">Jason A. Roberts</name></country><country name="France"><region name="Pays de la Loire"><name sortKey="Zahar, Jean Ralph" sort="Zahar, Jean Ralph" uniqKey="Zahar J" first="Jean Ralph" last="Zahar">Jean Ralph Zahar</name></region><name sortKey="Timsit, Jean Francois" sort="Timsit, Jean Francois" uniqKey="Timsit J" first="Jean-Francois" last="Timsit">Jean-Francois Timsit</name></country><country name="Royaume-Uni"><noRegion><name sortKey="Barton, Greg" sort="Barton, Greg" uniqKey="Barton G" first="Greg" last="Barton">Greg Barton</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002611 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002611 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:26169558
|texte= The ADMIN-ICU survey: a survey on antimicrobial dosing and monitoring in ICUs.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:26169558" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |